Lab
Labtest LLC
Labtest LLC was paid $74K by Medicaid between Nov 2020 and Sep 2023, across 53 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 37% of everything it billed.
33Billing provider infoLABTEST LLC
HOUSTON, TX 77074
HOUSTON, TX 77074
33aNPI1740820927assigned 01/15/2020
33bProvider typeClinical Medical Laboratory
28Total paid$74K
24GClaims22,098
24DCodes billed53
24AFirst – last monthNov 2020 – Sep 2023
Compared with peers
Next to other Clinical Medical Laboratory providers in Texas
Rank by total paid#161 of 436
Median peer was paid$17K
This provider vs. median4.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,102 | $3K | |
| 2021 | 12,243 | $37K | |
| 2022 | 6,610 | $34K | |
| 2023 | 1,143 | $289.73 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 37% | 470 | 428 | $27K |
| 80050 | General health panel | 15% | 1,711 | 1,458 | $11K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 10% | 392 | 360 | $8K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 9.2% | 1,606 | 1,345 | $7K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8.7% | 401 | 365 | $6K |
| 80061 | Lipid panel | 5.5% | 2,372 | 2,010 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.2% | 1,601 | 1,443 | $2K |
| 84439 | 2.9% | 2,025 | 1,662 | $2K | |
| 82607 | 1.9% | 1,011 | 784 | $1K | |
| 80053 | Comprehensive metabolic panel | 1.1% | 1,158 | 921 | $834.41 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 380 | 300 | $513.09 |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 27 | 26 | $501.58 |
41 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 987 | $474.04 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 112 | $448.30 |
| 84153 | <1% | 152 | $432.34 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 80 | $371.16 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 80 | $371.16 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 207 | $287.39 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 234 | $128.15 |
| 82746 | <1% | 155 | $69.15 | |
| 86696 | <1% | 14 | $48.75 | |
| 84481 | <1% | 67 | $42.69 | |
| 86803 | <1% | 13 | $42.67 | |
| 86695 | <1% | 14 | $33.24 | |
| 87340 | <1% | 13 | $30.89 | |
| 81001 | <1% | 201 | $29.92 | |
| 86592 | <1% | 50 | $27.30 | |
| 80299 | <1% | 118 | $23.80 | |
| 84436 | <1% | 459 | $17.25 | |
| 82728 | <1% | 60 | $16.83 | |
| 83550 | <1% | 76 | $14.61 | |
| 80346 | <1% | 108 | $13.53 | |
| 80356 | <1% | 108 | $13.36 | |
| 83690 | <1% | 71 | $11.81 | |
| 80349 | <1% | 108 | $11.27 | |
| 84479 | <1% | 450 | $10.80 | |
| 83540 | <1% | 77 | $10.80 | |
| 80353 | <1% | 108 | $10.25 | |
| 80359 | <1% | 108 | $5.00 | |
| 80366 | <1% | 106 | $5.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 3,711 | $0.00 |
| 80335 | 0% | 105 | $0.00 | |
| 82043 | 0% | 21 | $0.00 | |
| 80358 | 0% | 108 | $0.00 | |
| 84480 | 0% | 100 | $0.00 | |
| 83880 | 0% | 13 | $0.00 | |
| 80324 | 0% | 108 | $0.00 | |
| 82150 | 0% | 47 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 123 | $0.00 |
| 80361 | 0% | 60 | $0.00 | |
| 82248 | 0% | 12 | $0.00 | |
| 80369 | 0% | 108 | $0.00 | |
| 80365 | 0% | 92 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAIDER, SYED (CEO)
Parent organizationLABTEST LLC
| Provider | Location | Paid |
|---|---|---|
| Labtest LLC | Saint Louis, MO | $4.17M |
| Autism and Behavioral Spectrum LLC | Chesterfield, MO | $2.04M |
| Newborn and Pediatric Care of West Houston PLLC | Katy, TX | $570K |
| STL Diagnostic LLC | Saint Louis, MO | $320K |
| Cyber Diagnostic Medicine LLC | Florissant, MO | $198K |
| Sultana's Medical, LLC | Buffalo, NY | $58K |
| Belleville Diagnostic Center, LLC | Belleville, IL | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.